Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$820M |
| 2 |
Microsoft
MSFT
|
+$811M |
| 3 |
McDonald's
MCD
|
+$804M |
| 4 |
Coca-Cola
KO
|
+$655M |
| 5 |
Amazon
AMZN
|
+$646M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$1.64B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.1B |
| 3 |
Strategy Inc
MSTR
|
+$564M |
| 4 |
Kroger
KR
|
+$558M |
| 5 |
Danaher
DHR
|
+$494M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.33% |
| 2 | Healthcare | 3.23% |
| 3 | Consumer Discretionary | 2.55% |
| 4 | Financials | 2.55% |
| 5 | Industrials | 1.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PMA
11001
Ming Shing Group
PMA
$22.4M
| $138K | ﹤0.01% |
+29,197
| New | +$122K |
|
11002
CALL
Star Holdings Shares of Beneficial Interest
STHO
$118M
| $137K | ﹤0.01% |
17,600
+3,400
| +24% | +$23.5K |
|
|
SGMO
11003
CALL
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $137K | ﹤0.01% |
253,500
+68,800
| +37% | +$40.9K |
|
11004
PUT
AerSale
ASLE
$280M
| $137K | ﹤0.01% |
22,800
+15,900
| +230% | +$102K |
|
|
NINE
11005
PUT
DELISTED
Nine Energy Service
NINE
| $136K | ﹤0.01% |
177,000
+127,500
| +258% | +$93.5K |
|
11006
CALL
Pangaea Logistics
PANL
$487M
| $136K | ﹤0.01% |
29,000
+19,900
| +219% | +$88.4K |
|
|
SBC
11007
SBC Medical Group
SBC
$375M
| $136K | ﹤0.01% |
+29,366
| New | +$116K |
|
|
AGEN
11008
CALL
Agenus
AGEN
$329M
| $136K | ﹤0.01% |
29,800
-33,200
| -53% | -$115K |
|
11009
Polen Capital International Growth ETF
PCIG
$29.6M
| $136K | ﹤0.01% |
13,805
-13,803
| -50% | -$130K |
|
11010
CALL
Key Tronic
KTCC
$43.1M
| $136K | ﹤0.01% |
47,500
+46,400
| +4,218% | +$123K |
|
11011
Biote Corp
BTMD
$42.2M
| $136K | ﹤0.01% |
33,749
+14,268
| +73% | +$52.6K |
|
|
ZKH
11012
ZKH Group
ZKH
$463M
| $136K | ﹤0.01% |
44,140
+8,762
| +25% | +$26.3K |
|
11013
Citizens
CIA
$201M
| $135K | ﹤0.01% |
+38,691
| New | +$151K |
|
|
ZYXI
11014
DELISTED
Zynex
ZYXI
| $135K | ﹤0.01% |
52,304
-1,161
| -2% | -$2.63K |
|
11015
PUT
Flywire
FLYW
$2.29B
| $135K | ﹤0.01% |
11,500
-2,100
| -15% | -$21.4K |
|
11016
Dynagas LNG Partners
DLNG
$140M
| $134K | ﹤0.01% |
38,149
+5,948
| +18% | +$21.4K |
|
11017
Orthofix Medical
OFIX
$421M
| $134K | ﹤0.01% |
12,043
-93,452
| -89% | -$1.16M |
|
11018
CALL
VistaGen Therapeutics
VTGN
$11.9M
| $134K | ﹤0.01% |
67,100
+58,200
| +654% | +$132K |
|
|
BCIC
11019
PUT
BCP Investment Corp
BCIC
$94.7M
| $134K | ﹤0.01% |
10,700
+3,100
| +41% | +$37.9K |
|
11020
PUT
Ginkgo Bioworks
DNA
$457M
| $134K | ﹤0.01% |
11,898
-57,196
| -83% | -$443K |
|
11021
PUT
Olema Pharmaceuticals
OLMA
$930M
| $134K | ﹤0.01% |
31,400
+16,200
| +107% | +$72.2K |
|
11022
CALL
RE/MAX Holdings
RMAX
$268M
| $133K | ﹤0.01% |
16,300
+5,900
| +57% | +$45.8K |
|
11023
CALL
Arena Group
AREN
$54.8M
| $133K | ﹤0.01% |
21,500
+18,600
| +641% | +$91.4K |
|
|
CAN
11024
CALL
Canaan Creative
CAN
$171M
| $133K | ﹤0.01% |
215,400
+59,400
| +38% | +$41.8K |
|
11025
CALL
Inovio Pharmaceuticals
INO
$113M
| $133K | ﹤0.01% |
65,400
+57,700
| +749% | +$111K |
|
Similar funds
Citadel Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Citadel Advisors held 15,819 positions worth $576B, up 9.2% from $527B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Citadel Advisors withdrew a net $29.1B in Q2 2025, closing 3,524 positions and reducing 5,141 holdings. Its most notable exit was Kroger, an estimated $558M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.3% of assets, up from 2.9% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in Walmart Inc worth $401M.
- Citadel Advisors's largest Q2 2025 buy was Walmart Inc: 4,099,492 shares worth $401M.
- Citadel Advisors added most to NVIDIA in Q2 2025, an estimated $820M increase.
- Citadel Advisors's biggest Q2 2025 reduction was Charles Schwab, cutting an estimated $1.64B.
- Citadel Advisors fully exited Kroger in Q2 2025, selling an estimated $558M.
- Citadel Advisors's ten largest holdings make up 27% of its $576B portfolio in Q2 2025.
- Citadel Advisors opened 1,459 new positions and closed 3,524 in Q2 2025.
- Citadel Advisors's portfolio value rose 9.2% quarter-over-quarter to $576B.
Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.